Using a 3D human neural cell culture model, researchers showed that this hormone leads to the production of the enzyme neprilysin, which decreases the presence of amyloid beta, according to the study, which was published Sept. 8 in the journal Neuron.
The findings could reveal “a new target pathway for therapies aimed at the prevention and treatment of Alzheimer’s disease,” Rudolph Tanzi, PhD, a senior author of the study and the director of the Genetics and Aging Research Unit, said in a press release.
